2000•GastroenterologyOpen access

Comparison of daily induction dose interferon alpha 2b plus ribavirin followed by daily combination therapy versus standard combination therapy in treatment naive patients with chronic hepatitis C

Eric Lawitz, Shailesh C. Kadakia, N CANTU, Mark Jeffries, Steven M. Schutz, Harry Matossian, John J. Jolley, Alan J. Sheinbaum, John G. Meadows

Open full text 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Ribavirin, Medicine, Chronic hepatitis, Combination therapy, Alpha interferon, Alpha (finance), Induction therapy, Rescue therapy

Back to paper search Browse research topics Original source

Comparison of daily induction dose interferon alpha 2b plus ribavirin followed by daily combination therapy versus standard combination therapy in treatment naive patients with chronic hepatitis C — Research Paper | ScholarLens